Anti-C1q autoantibodies are frequently detected in lupus nephritis (LN) [73,74] and it is possible that autoantibodies targeting other proteins linked to classical complement activation, e.g., CRP, could affect the complement-mediated clearance of cellular debris [75,76]. This evidence concerns the gene CRP and lobular neoplasia.